CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Blogs
Florida bill will not distinguish delta-8 THC from other hemp-derived products
Written by Freddie Dawson | 16th December 2021
What do Luxembourg and Malta’s legal cannabis plans mean in practice?
Written by Freddie Dawson | 9th December 2021
New German coalition plans to legalise cannabis – but when will sales begin?
Written by Freddie Dawson | 25th November 2021
Why are specialist vape retailers around the world turning away from CBD online?
Written by Freddie Dawson | 17th November 2021
eBay prepares to take on Amazon with the launch of UK trial of CBD sales
Written by Freddie Dawson | 10th November 2021
The suspense continues, still with no end in sight to the UK’s novel food saga
Written by Freddie Dawson | 3rd November 2021
US states fall over themselves backwards to sow further confusion over delta-8
Written by Anthony Traurig | 21st October 2021
Charlotte’s Web new dietary ingredient application did include ValidCare data
Written by Freddie Dawson | 14th October 2021
Could CBD companies face scrutiny from another US regulatory agency?
Written by Freddie Dawson | 6th October 2021
What does the recent USPTO trademark decision mean for the industry?
Written by Freddie Dawson | 22nd September 2021
FDA and CDC warnings won’t signal the end of the delta-8 THC market in the US
Written by Freddie Dawson | 16th September 2021
Beverage brands still searching for the right solution to their drink problem
Written by CannIntelligence | 9th September 2021
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
Written by CannIntelligence | 1st September 2021
What conclusions can be drawn from the FDA rejection of full hemp extracts as supplements?
Written by CBD-Intel | 18th August 2021
What lies behind the CBD industry’s continued interest in the field of nicotine replacement?
Written by CBD-Intel | 11th August 2021
Could e-cig ‘shake and vape’ be a model for sales of ingestible CBD products?
Written by CBD-Intel | 5th August 2021
What can be concluded from the appointment of Lina Khan as new chair of the Federal Trade Commission (FTC)?
Written by CBD-Intel | 22nd July 2021
EU novel food assessment: No easy end in sight
Written by CBD-Intel | 16th July 2021
Why the UK government might not follow task force advice on homegrown hemp
Written by CannIntelligence | 8th July 2021
UK taskforce urges reform – but will it happen, and will it boost the market?
Written by Freddie Dawson | 28th June 2021
Why is crowd-funding an increasingly popular option for CBD companies to raise investment?
Written by JuditBach | 21st June 2021
What changes can be expected in the near future for the regulation of CBD in France?
Written by JuditBach | 11th June 2021
New UK cannabis industry body brings together a wide range of expertise
Written by CannIntelligence | 3rd June 2021
Is delta-8 THC a legal product in the US?
Written by CannIntelligence | 20th May 2021
What can we learn from the distribution of brands by main product category and retailer type in the UK?
Written by CannIntelligence | 14th May 2021
Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?
Written by CannIntelligence | 7th May 2021
What is the state of science behind minor cannabinoids really like?
Written by CannIntelligence | 29th April 2021
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
Written by CannIntelligence | 22nd April 2021
Is delta-8 THC really the next big thing?
Written by CannIntelligence | 14th April 2021
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
Written by CannIntelligence | 8th April 2021
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
Written by CannIntelligence | 1st April 2021
Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?
Written by CannIntelligence | 25th March 2021
With ingredient prices tumbling, why are CBD consumers still paying so much?
Written by Nate Erskine | 18th March 2021
Will the FSA-validated novel food submission list reveal commercially sensitive information?
Written by CannIntelligence | 11th March 2021
How long will it take to see validated assessments from the UK Food Standards Agency (FSA)?
Written by CannIntelligence | 4th March 2021
Could the Biden administration bring a new approach to enforcement of CBD health claims?
Written by CannIntelligence | 26th February 2021
Have the rules changed for importation of CBD into the UK?
Written by CannIntelligence | 18th February 2021
Will the EFSA look to modify its approach in light of action on novel food in the UK?
Written by CannIntelligence | 12th February 2021
How seriously should producers of CBD alcohol products take the recent Portman Group ruling?
Written by CannIntelligence | 5th February 2021
What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?
Written by CannIntelligence | 28th January 2021
Is the entrance of British American Tobacco (BAT) into the CBD sector a positive or negative for the industry?
Written by CannIntelligence | 22nd January 2021
Does the Canopy CO2 extraction lawsuit pose a threat to others in the industry?
Written by CannIntelligence | 15th January 2021
What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?
Written by CannIntelligence | 8th January 2021
Do CBD firms expect much of a January uptick in sales?
Written by CannIntelligence | 18th December 2020
How far-reaching an impact could the CJEU Kanavape decision have?
Written by CannIntelligence | 11th December 2020
What does the European Commissions (EC)’s change in opinion on CBD as a narcotic mean?
Written by CannIntelligence | 4th December 2020
What impact will Black Friday sales have on the CBD sector?
Written by CannIntelligence | 27th November 2020
How important is the CJEU decision on the Kanavape case?
Written by CannIntelligence | 20th November 2020
Where are we most likely to see changes to medical and recreational cannabis regimes?
Written by CannIntelligence | 13th November 2020
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
Your display name will appear here.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.